📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nucleonics

1.1 - Company Overview

Nucleonics Logo

Nucleonics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of RNA interference-based therapeutics as a biotechnology company.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nucleonics

Discuva Logo

Discuva

HQ: United Kingdom Website
  • Description: Provider of next-generation antibiotic discovery, Cambridge (UK)-based, established to address major gaps in the treatment of infective disease using proprietary methods, and developer of Ivonescimab (SMT112), a bispecific PD-1/VEGF antibody for oncology in Phase III trials for non-small cell lung cancer and other solid tumors, with over 1,600 patients treated.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Discuva company profile →
Verax Biomedical Logo

Verax Biomedical

HQ: United States Website
  • Description: Provider of rapid tests for detecting bacterial contamination in cellular components for transfusion or transplant, including FDA-cleared Platelet PGD and PGDprime tests (now detecting Acinetobacter) and 7 Day Platelet Dating with PGD enabling 7-day platelet dating to improve platelet safety and availability while reducing costs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Verax Biomedical company profile →
Abivax Logo

Abivax

HQ: France Website
  • Description: Provider of clinical-stage biotechnology therapies that mobilize the body's natural immune machinery to treat autoimmune diseases, viral infections, and cancer, including obefazimod for ulcerative colitis (Phase 3), planned Phase 2b for Crohn's disease, exploration as combination therapy for ulcerative colitis in preclinical studies, and nonclinical evaluation for additional chronic inflammatory indications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Abivax company profile →
Arbutus Biopharma Logo

Arbutus Biopharma

HQ: Canada Website
  • Description: Provider of biopharmaceutical therapies for hepatitis B virus (HBV), including Imdusiran (AB-729), a subcutaneously delivered RNAi therapeutic designed to reduce HBV viral antigens such as HBsAg, and AB-101, an oral PD-L1 inhibitor intended to reawaken HBV-specific T cells by blocking the PD-1/PD-L1 protein-protein interaction.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arbutus Biopharma company profile →
Excelimmune Logo

Excelimmune

HQ: United States Website
  • Description: Provider of fully human recombinant polyclonal antibodies for therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Excelimmune company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nucleonics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nucleonics

2.2 - Growth funds investing in similar companies to Nucleonics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nucleonics

4.2 - Public trading comparable groups for Nucleonics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nucleonics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nucleonics

What does Nucleonics do?

Nucleonics is a provider of RNA interference-based therapeutics as a biotechnology company.

Who are Nucleonics's competitors?

Nucleonics's competitors and similar companies include Discuva, Verax Biomedical, Abivax, Arbutus Biopharma, and Excelimmune.

Where is Nucleonics headquartered?

Nucleonics is headquartered in United States.

How many employees does Nucleonics have?

Nucleonics has 1,000 employees 🔒.

When was Nucleonics founded?

Nucleonics was founded in 2010 🔒.

What sector and industry vertical is Nucleonics in?

Nucleonics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nucleonics

Who are the top strategic acquirers in Nucleonics's sector and industry

Top strategic M&A buyers and acquirers in Nucleonics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nucleonics?

Top strategic M&A buyers groups and sectors for Nucleonics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nucleonics's sector and industry vertical

Which are the top PE firms investing in Nucleonics's sector and industry vertical?

Top PE firms investing in Nucleonics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nucleonics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nucleonics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nucleonics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nucleonics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nucleonics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nucleonics?

The key public trading comparables and valuation benchmarks for Nucleonics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nucleonics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nucleonics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nucleonics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nucleonics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nucleonics's' sector and industry vertical?

Access recent funding rounds and capital raises in Nucleonics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nucleonics